Send to

Choose Destination
Oncol Rev. 2018 Jan 30;12(1):345. doi: 10.4081/oncol.2018.345. eCollection 2018 Jan 30.

Punica granatum (Pomegranate) activity in health promotion and cancer prevention.

Author information

Medical Mycology Department, Pasteur Institute of Iran, Thran, Iran.


Cancer has become one of the most fatal diseases in most countries. In spite of the medical care developing, cancer still remains a significant problem. The majority of the cancers are resistant to treatment. Thus, the research for novel, more efficient and less side effect treatment methods continues. Pomegranate contains strong antioxidant activity, with potential health interests. Research concern in pomegranate is increasing because of their anticancer potential due to possess rich in polyphenols. We highlight the pomegranate potential health benefits and mechanism of cancer progression inhibition. Pomegranate has indicated antiproliferative, anti-metastatic and anti-invasive effects on different cancer cell line in vitro, in vivo and clinical trial. The aim of this review is to evaluate functional properties and the medical benifits of pomegranate against various cancer diseases. In addition, pomegranate properties in in vitro and in vivo experimental human and animal clinical trials and its future use are explored. The available data suggest that Punica granatum (pomegranate) might be used in the control and potential therapeutic for some disease conditions and benefits human health status. This review summarizes in vitro, in vivo and clinical trial studies highlighting the pomegranate role in prevent and treatment of breast, prostate, lung, colon, skin and hepatocellular cell cancers.


Punica granatum (pomegranate); cancer; natural product; prevention and control; treatment

Supplemental Content

Full text links

Icon for Pagepress Publications Icon for PubMed Central
Loading ...
Support Center